121. Seasonal Allergic Rhinitis - FDA Approves CLARINEX-D Gel 24 HOUR Prescription-St Unique Gel Control delivery system provides effective 24hour relief - Schering-PloughCorporation (NYSE SGP) today announced that the US Food and Drug http://www.medicalnewstoday.com/medicalnews.php?newsid=20742

122. Management Of Allergic And Nonallergic Rhinitis: Clinical Focus How does one diagnose allergic and nonallergic rhinitis? What differentiatesallergic from nonallergic rhinitis with respect to symptoms, signs, http://www.ahrq.gov/clinic/tp/rhintp.htm

Allergic and Nonallergic Rhinitis May 2002 Clinical Focus* How does one diagnose allergic and nonallergic rhinitis? What differentiates allergic from nonallergic rhinitis with respect to symptoms, signs, physical examinations, and diagnostic testing? What is the minimum level of testing necessary to differentiate allergic from nonallergic rhinitis? Is differentiating allergic from nonallergic rhinitis important? Are treatments different? Are outcomes different? How does one treat nonallergic and allergic rhinitis? For nonallergic, what is the efficacy of antihistamines versus placebo? Nasal corticosteroids versus placebo? Sympathomimetics versus placebo? Leukotriene modifiers versus placebo? Anticholinergics versus placebo? Chromaglycate versus placebo? What are the side effects/adverse events due to drug treatments? For allergic, seasonal rhinitis, what is the efficacy of antihistamines versus nasal corticosteroids? Antihistamines versus immunotherapy? Nasal steroids versus immunotherapy? Sedating versus nonsedating antihistamines? Other agents? What are the side effects/adverse events due to drug treatments? How do efficacy and side effects of treatments vary by severity of rhinitis, patient chracteristics? How does the treatment of allergic rhinitis impact on the development of asthma? What is the likelihood of developing asthma with untreated allergic rhinitis?

123. Allergies (Allergic Rhinitis) - DrGreene.com An article defining childhood allergies, its symptoms, family genetics, treatmentand prevention. http://www.drgreene.com/21_1023.html

QUICK SEARCH A - Z Guide ADHD Allergy Care Guide Allergies Asthma Care Guide Asthma Bedwetting Breastfeeding Childhood Obesity Diabetes Care Guide Ear Infections Environmental Health Genetics Infectious Diseases Medical Treatment Mental Health Multimedia Library Potty Training Rashes Safety Sleep About DrGreene.com Archives About Us Context Reviews Awards Readers Comments Press Room Partners and Supporters Children's Health Topic Centers Contact Us Professional Resources Dr. Greene's Welcome Analytical Chemistry Business: Healthcare Cardiology Clinical Pharmacology Clinical Trials Mgmt Cosmetic Surgery Dermatology Diabetes Drug Discovery Emergency Medicine Endocrinology Family Practice Gastroenterology Geriatrics HIV/AIDS Infectious Disease Internal Medicine Managed Care Neurology Nursing Ob/Gyn Oncology Ophthalmology Orthopedics Pediatrics Pharma Marketing Pharma Sales Pharma Science/Tech Pharmacy Psychiatry Pulmonology Radiology Residents / Students Rheumatology Surgery Urology Pediatric Information A-Z Guide Allergy Care Guide Asthma Care Guide Diabetes Care Guide Discussion Boards Dr. Greene´s Chats

124. NEJM -- Evaluation Of Impermeable Covers For Bedding In Patients With Allergic R The severity of rhinitis was measured on a rhinitisspecific Impermeable BedCovers for Asthma and rhinitis Testing Conventional Wisdom. http://content.nejm.org/cgi/content/abstract/349/3/237

HOME SEARCH CURRENT ISSUE PAST ISSUES ... HELP Please sign in for full text and personal services Previous Volume 349:237-246 July 17, 2003 Number 3 Next Evaluation of Impermeable Covers for Bedding in Patients with Allergic Rhinitis Ingrid Terreehorst, M.D., Eelko Hak, Ph.D., Albert J. Oosting, M.D., Ph.D., Zana Tempels-Pavlica, M.D., Jan G.R. de Monchy, M.D., Ph.D., Carla A.F.M. Bruijnzeel-Koomen, M.D., Ph.D., Rob C. Aalberse, Ph.D., and Roy Gerth van Wijk, M.D., Ph.D. Full Text PDF PDA Full Text Perspective ... PubMed Citation ABSTRACT Background Encasing bedding in impermeable covers reduces exposure to house-dust mites, but the clinical benefit of this intervention as part of mite-avoidance measures for patients with allergic rhinitis is not known. We performed a multicenter, randomized, placebo-controlled trial of one year of use of impermeable bedding covers in the bedrooms of patients with rhinitis who were sensitized to house-dust mites to determine the effects on the signs and symptoms of disease. Methods Three participating university medical centers enrolled 279 patients with allergic rhinitis who were randomly assigned to receive impermeable or non-impermeable (control) covers for their mattress, pillow, and duvet or blanket. At the start of

125. Allergic Rhinitis Allergic rhinitis is an inflammation of the nasal passages, Allergic rhinitisaffects about 20 percent of the American population and ranks as one of http://ww3.komotv.com/Global/story.asp?S=1228718

126. Dog Model Of Asthma And Allergic Rhinitis - Lovelace Respiratory Research Instit Dog Model of Asthma and Allergic rhinitis dog model of asthma, allergicrhinitis, and allergic dermatitis for studies of drug efficacy and pharmacology. http://www.lrri.org/kc/PofD/dogmodel.html

Key Capabilities Pathobiology of Disease Emphysema and Bronchitis Research Lung Immunology and Asthma Dog Model of Asthma/Allergic Rhinitis ... BSL-3 Facilities Dog Model of Asthma and Allergic Rhinitis Lovelace Respiratory Research Institute (LRRI) offers the Beagle dog model of asthma, allergic rhinitis, and allergic dermatitis for studies of drug efficacy and pharmacology. Dogs treated with ragweed or house dust mite extract develop sensitive airways that reversibly constrict. Dogs maintain allergic response over time after repeated exposures to ragweed. Sensitized dogs also develop inflammatory and other allergic responses in the lung (elevated total and specific IgE; eosinophils). Some common asthma medications such as albuterol and oral steroids effectively relieve the airway constriction caused by a ragweed exposure. Finally, acoustic rhinometry can assess nasal obstruction in the dog model after a challenge of ragweed. Allergy drugs such as d-pseudoephedrine block ragweed-induced nasal congestion. CHARACTERISTICS OF OUR DOG MODEL: Natural development of allergic disease Sensitization of ragweed and dust mites IgE-mediated sensitivity Immediate airway responses to allergen Chronic inflammation Localized immune response in the lung EXPERIMENTAL CAPABILITIES: Eosinophils: Effects of anti-inflammatory drugs on recruitment and activation of eosinophils Cytokines: IL-2, -4, -8, -10,-12, -13, INF

127. ARIA http://www.whiar.com/

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 7     121-127 of 127    Back | 1  | 2  | 3  | 4  | 5  | 6  | 7